Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …

Drug addiction is a chronically relapsing disorder characterized by the compulsive desire to
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Objective The drug poisoning crisis throughout North America necessitates novel harm
reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some …

Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and
clinicians are challenged with understanding the implications of CBD for treating mental …

Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …

Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …

Background Cannabinoids may have an important therapeutic potential for the treatment of
dependence on crack cocaine. Cannabidiol (CBD), in particular, has anxiolytic …

Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

Currently, there are no approved pharmacotherapies for addiction to cocaine and other
psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a …